Orem Family Medicine

CLIA Laboratory Citation Details

5
Total Citations
25
Total Deficiencyies
15
Unique D-Tags
CMS Certification Number 46D0991303
Address 173 N 400 W Ste C-11, Orem, UT, 84057
City Orem
State UT
Zip Code84057
Phone801 802-7373
Lab DirectorSTEVEN BERRY

Citation History (5 surveys)

Survey - April 9, 2024

Survey Type: Standard

Survey Event ID: QIIY11

Deficiency Tags: D5401 D5401

Summary:

Summary Statement of Deficiencies D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on record review, lack of documentation and an interview with Testing Personnel #2 (TP #2), the laboratory failed to establish written procedures for the moderately complex Affirm VP III assay for bacteriology testing since the last survey performed on 4/11/2022. The laboratory performs 240 bacteriology tests annually. Findings include: 1. Record review on 4/9/2024 at approximately 12:20 PM, revealed that the laboratory failed to establish written procedures for the Affirm VP III assay since the last survey performed on 4/11/2022 . 2. An interview with TP #2 on 4/9/24 at approximately 12:20 PM, confirmed that the laboratory failed to establish written procedures for the Affirm VP III assay. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 11, 2022

Survey Type: Standard

Survey Event ID: 699J11

Deficiency Tags: D2009 D6054 D2009 D6054

Summary:

Summary Statement of Deficiencies D2009 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The individual testing or examining the samples and the laboratory director must attest to the routine integration of the samples into the patient workload using the laboratory's routine methods. This STANDARD is not met as evidenced by: Based on record review of proficiency testing performance evaluations and interview with the back office manager, the laboratory failed to attest that proficiency testing samples were tested in the same manner as patient specimens, for 1 of 2 proficiency testing performance evaluations. Findings include: 1. A review of the proficiency testing performance evaluations on 4/11/22 at 11:30 am revealed that the laboratory director or designee failed to sign the attestation statement for the American Proficiency Institute (API) 2021 Microbiology - 3rd event. 2. In an interview on 4/11 /22 at 11:40 am, the back office manager confirmed that the laboratory director or designee failed to sign the attestation statement. D6054 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(9) The technical consultant is responsible for evaluating and documenting the performance of individuals responsible for moderate complexity testing at least annually, after the first year. This STANDARD is not met as evidenced by: Based on a review of personnel competency assessments and interview with the back office manager, the laboratory failed to maintain documentation of annual competency for 1 of 12 testing personnel responsible for moderate complexity testing. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- Findings include: 1. A review of personnel competency assessments on 4/11/22 at 12: 00 pm, revealed that documentation for TP1, at time of survey, was not available for the years 2020 or 2021. 2. In an interview on 4/11/22 at 12:05 pm, the back office manager confirmed that annual competency assessment documentation was not available for TP1 for the years 2020 or 2021. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 17, 2019

Survey Type: Standard

Survey Event ID: GUCU11

Deficiency Tags: D5411 D5461 D6036 D6063 D6065 D5211 D5411 D5461 D6036 D6063 D6065

Summary:

Summary Statement of Deficiencies D5211 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(a) The laboratory must review and evaluate the results obtained on proficiency testing performed as specified in subpart H of this part. This STANDARD is not met as evidenced by: Based on proficiency testing reports review, lack of documentation and interview with staff, the laboratory failed to review and evaluate American Proficiency Institute (API) testing results for 4 of 4 testing events the laboratory scored 0% or 60% for Trichomonas presence or absence identification. Findings include: 1. The first event of 2017 the laboratory reported the instrument was not in service. The laboratory was excused from participation. 2. The second event of 2017 the laboratory received a 60% score for Trichomonas presence or absence, The laboratory reported VP 07 as negative for Trichomonas. The correct response was positive. The laboratory reported VP 08 as positive. The correct response was negative. 3. The third event of 2017 the laboratory failed to return proficiency testing results within the established timeframe and received a score of 0% for Trichomonas identification presence or absence. The laboratory did not self grade their test results to those expected. (The lab would have passed with an 80% score had they self graded.) 4. The first event of 2018 the laboratory failed to participate in proficiency testing receiving a score of 0%. The laboratory lacked documentation they performed the test samples. 5. In an interview conducted on 04/17/2019 at approximately 4:40 P.M. staff stated the laboratory lacked documentation they evaluated their results and verified the test was performing accurately and precisely when their scores did not reflect passing performance. D5411 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(a) Test systems must be selected by the laboratory. The testing must be performed Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 4 -- following the manufacturer's instructions and in a manner that provides test results within the laboratory's stated performance specifications for each test system as determined under 493.1253. This STANDARD is not met as evidenced by: Based on Affirm VP manufacturer's instructions for DNA extraction review, patient test records review, and confirmation by staff, the laboratory failed to ensure specimens were incubated at 85 degrees for at least 10 minutes, but less than 20 minutes, for 3 of approximately 160 specimens reviewed from 06/16/2019 to 04/08 /2019. Findings include: 1. VP Affirm manufacturer's instructions stated the laboratory was to incubate vaginal specimens at 85 degrees using the extraction reagent for 10 minutes but not more than 20 minutes. The instructions stated the lab should use a timer. 2. Laboratory test records reviewed included documentation the laboratory failed to monitor the incubation times for specimens 791819 on 06/21 /2017, 128337 on 04/29/2017, 1375985 on 10/04/2017, and 1147587 on 03/24/2019. 3. In an interview with staff on 04/17/2019 the laboratory staff stated testing personnel were to set the timers on their cell phones to remind them to return to the location where the specimen was incubating. It was not determined if timers were not set, not heard, or if staff was not able to return to complete the DNA extraction process for 24 hour specimen stabilization for testing within 24 hours. THIS IS A REPEAT DEFICIENCY. D5461 CONTROL PROCEDURES CFR(s): 493.1256(d)(6)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- Perform control material testing as specified in this paragraph before resuming patient testing when a complete change of reagents is introduced; major preventive maintenance is performed; or any critical part that may influence test performance is replaced. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on patient test records review, lack of documentation, and interview with staff, the laboratory failed to perform quality control for new lot numbers of Affirm VP tests for 3 of 12 lot numbers reviewed from 06/16/2017 to 04/08/2019. The laboratory performed approximately 160 tests per year for Candida, Gardnerella, and Trichomonas presence or absence using the Affirm VP test system. Findings include: 1. Patient test records review included documentation the laboratory performed patient testing using VP Affirm Kit lot numbers 8312959 for patient testing for patient 429991 on 03/13/2019 without performing a known positive Trichomonas quality control; for Kit lot number 732562 for patient number 428491 on 05/01/2018 ; Kit lot number 732562 on 11/08/2017 for patient 886041; and for Kit lot number 6286517 on 08/03/2017 for patient number 424568 the laboratory reported patient test results without performing external known positive and negative quality control for Candida, Gardnerella, and Trichomonas . 2. The laboratory lacked documentation kit lot numbers listed in finding number 1 had 2 levels of external controls for Candida, Gardnerella, and Trichomonas performed prior to testing patient specimens. 3. In an interview conducted on 04/17/2019 at approximately 4:45 P.M. the laboratory staff confirmed the laboratory did not have quality control performance documentation recorded prior to testing patient samples. THIS IS A REPEAT DEFICIENCY. -- 2 of 4 -- D6036 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413 The technical consultant is responsible for the technical and scientific oversight of the laboratory. This STANDARD is not met as evidenced by: Based on competency evaluations review, lack of the technical consultant's signature, and confirmation by staff, the laboratory technical consultant failed to evaluate testing personnel for one of two years of testing performed (2018) for 4 of 4 testing personnel performing moderate complexity testing in 2018. Findings include: 1. Testing personnel competency evaluations review lacked the signature of the laboratory technical consultant as documentation the qualified technical consultant evaluated moderate complexity testing personnel by directly observing routine patient testing performance, recording and reporting test results, reviewing intermediate test results or worksheets, quality control records, directly observing instrument maintenance and function checks, assessing test performance through previously tested specimens, internal blind testing samples or external proficiency tests (proficiency tests not self graded), assessment of problem solving skills and evaluating personnel annually after the first year of testing for AffrimVP testing for the presence or absence of Candida, Gardnerella, and Trichomonas organisms. 2. In an interview conducted on 04/17/2019 at approximately 4:50 P.M. laboratory staff confirmed competency evaluations were performed by other testing staff members who were not qualified to be the technical consultant. D6063 LABORATORY TESTING PERSONNEL CFR(s): 493.1421 The laboratory must have a sufficient number of individuals who meet the qualification requirements of 493.1423, to perform the functions specified in 493. 1425 for the volume and complexity of tests performed. This CONDITION is not met as evidenced by: Based on lack of documentation and interview with staff, the laboratory failed to ensure 1 of 7 new testing personnel met the qualifications for moderate complexity testing personnel. (See D6065.) D6065 TESTING PERSONNEL QUALIFICATIONS CFR(s): 493.1423(b)(1)(2)(3)(4)(i) (b) Meet one of the following requirements: (b)(1) Be a doctor of medicine or doctor of osteopathy licensed to practice medicine or osteopathy in the State in which the laboratory is located or have earned a doctoral, master's, or bachelor's degree in a chemical, physical, biological or clinical laboratory science, or medical technology from an accredited institution; or (b)(2) Have earned an associate degree in a chemical, physical or biological science or medical laboratory technology from an accredited institution; or (b)(3) Be a high school graduate or equivalent and have successfully completed an official military medical laboratory procedures course of at least 50 weeks duration and have held the military enlisted occupational specialty of Medical Laboratory Specialist (Laboratory Technician); or (b)(4)(i) Have earned a high school diploma or equivalent; and -- 3 of 4 -- This STANDARD is not met as evidenced by: Based on personnel test list review, testing personnel qualification records review, lack of documentation, and interview with staff, one of seven new testing personnel failed to have education documentation to qualify as a moderate complexity testing person. Findings include: 1. Personnel test list review included test person B who was trained to perform Affirm VP testing for the presence or absence of Candida, Gardnerella, and Trichomonas organisms from vaginal swabs on 02/27/2019. 2. Personnel qualification records review failed to include a diploma or transcript for Test person B to qualify as a moderate complexity testing person. 3. In an interview with the laboratory staff, on 04/17/2019 at approximately 4:50 P.M. staff confirmed Test person B did not have a copy of a transcript or diploma to qualify as a moderate complexity testing person. -- 4 of 4 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - August 29, 2018

Survey Type: Standard

Survey Event ID: ZWY912

Deficiency Tags: D5805 D2015 D5449 D6021

Summary:

Summary Statement of Deficiencies No Tags No deficiency details available. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 26, 2018

Survey Type: Special

Survey Event ID: YOMG11

Deficiency Tags: D2016 D2028 D2016 D2028

Summary:

Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: The laboratory failed to successfully participate in proficiency testing (PT) for the sub- specialty of Bacteriology by failing to achieve a satisfactory score of at least 80% in 2 of 3 consecutive testing events. (See D2028) D2028 BACTERIOLOGY CFR(s): 493.823(e) Failure to achieve an overall testing event score of satisfactory performance for two consecutive testing events or two out of three consecutive testing events is Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- unsuccessful performance. This STANDARD is not met as evidenced by: Based on Federal Casper Report 155 and American Proficiency Institute (API) proficiency testing (PT) report review, the laboratory failed to achieve a satisfactory score of at least 80% in 2 consecutive testing events (event 3 of 2017 and event 1 of 2018) for the sub-specialty of Bacteriology resulting in unsuccessful PT performance. Findings include: 1. Casper and API PT reports document an unsatisfactory score of 0% in Bacteriology for event 3 of 2017. 2. Casper and API PT reports document an unsatisfactory score of 0% in Bacteriology for event 1 of 2018. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access